₹195.5
(Inclusive of all Taxes)
₹29.3 Cashback (15%)
Prescription drugWhats That
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Also Explore
निर्माता/विपणनकर्ता :
इप्का लैबोरेटरीज लिमिटेड
सेवन प्रकार :
मौखिक
वापसी नीति :
वापसी योग्य नहीं
इस तारीख को या बाद में समाप्त हो रहा है :
Jan-27
Drug-Drug Interactions
Critical
Critical
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with Telfirst-CT 40/6.25 Tablet:
Co-administration of Aliskiren with Telfirst-CT 40/6.25 Tablet can increase the risk of hyperkalemia (high potassium levels in the blood).
How to manage the interaction:
Taking Telfirst-CT 40/6.25 Tablet with Aliskiren can possibly lead to an interaction, please consult a doctor before taking it. Do not discontinue the medications without consulting a doctor.
Co-administration of Aliskiren with Telfirst-CT 40/6.25 Tablet can increase the risk of hyperkalemia (high potassium levels in the blood).
How to manage the interaction:
Taking Telfirst-CT 40/6.25 Tablet with Aliskiren can possibly lead to an interaction, please consult a doctor before taking it. Do not discontinue the medications without consulting a doctor.
Critical
How does the drug interact with Telfirst-CT 40/6.25 Tablet:
Co-administration of Telfirst-CT 40/6.25 Tablet and cisapride may increase the risk or severity of an irregular heart rhythm that may be serious.
How to manage the interaction:
Taking Telfirst-CT 40/6.25 Tablet with Cisapride is not recommended, please consult your doctor before taking it. Do not discontinue the medication without consulting a doctor.
Co-administration of Telfirst-CT 40/6.25 Tablet and cisapride may increase the risk or severity of an irregular heart rhythm that may be serious.
How to manage the interaction:
Taking Telfirst-CT 40/6.25 Tablet with Cisapride is not recommended, please consult your doctor before taking it. Do not discontinue the medication without consulting a doctor.
How does the drug interact with Telfirst-CT 40/6.25 Tablet:
Taking spironolactone with Telfirst-CT 40/6.25 Tablet may increase potassium levels in the blood.
How to manage the interaction:
Although there is a possible interaction, Telfirst-CT 40/6.25 Tablet can be taken with spironolactone if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking spironolactone with Telfirst-CT 40/6.25 Tablet may increase potassium levels in the blood.
How to manage the interaction:
Although there is a possible interaction, Telfirst-CT 40/6.25 Tablet can be taken with spironolactone if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Severe
How does the drug interact with Telfirst-CT 40/6.25 Tablet:
Co-administration of amiloride with Telfirst-CT 40/6.25 Tablet may increase potassium levels in the blood. (High potassium levels can cause hyperkalemia, which can lead to kidney failure, muscular paralysis, abnormal heart rhythm).
How to manage the interaction:
Although there is a possible interaction, amiloride may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is important to maintain proper fluid intake while taking these medications. Do not stop using any medications without talking to a doctor.
Co-administration of amiloride with Telfirst-CT 40/6.25 Tablet may increase potassium levels in the blood. (High potassium levels can cause hyperkalemia, which can lead to kidney failure, muscular paralysis, abnormal heart rhythm).
How to manage the interaction:
Although there is a possible interaction, amiloride may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is important to maintain proper fluid intake while taking these medications. Do not stop using any medications without talking to a doctor.
Severe
How does the drug interact with Telfirst-CT 40/6.25 Tablet:
Taking trimethoprim with Telfirst-CT 40/6.25 Tablet may increase potassium levels in the blood.
How to manage the interaction:
Although there is an interaction between Telfirst-CT 40/6.25 Tablet and trimethoprim, they can be taken together if prescribed by a doctor. However, consult a doctor if you experience nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, and a weak pulse. Do not discontinue the medications without consulting a doctor.
Taking trimethoprim with Telfirst-CT 40/6.25 Tablet may increase potassium levels in the blood.
How to manage the interaction:
Although there is an interaction between Telfirst-CT 40/6.25 Tablet and trimethoprim, they can be taken together if prescribed by a doctor. However, consult a doctor if you experience nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, and a weak pulse. Do not discontinue the medications without consulting a doctor.
Severe
How does the drug interact with Telfirst-CT 40/6.25 Tablet:
Taking tizanidine with Telfirst-CT 40/6.25 Tablet may have additive effects in lowering the blood pressure.
How to manage the interaction:
Although there is a possible interaction, Telfirst-CT 40/6.25 Tablet can be taken with tizanidine if prescribed by your doctor. Consult the prescriber if you experience symptoms of low blood pressure, such as headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate. Be cautious when getting up from a sitting or lying position. Do not discontinue the medications without consulting a doctor.
Taking tizanidine with Telfirst-CT 40/6.25 Tablet may have additive effects in lowering the blood pressure.
How to manage the interaction:
Although there is a possible interaction, Telfirst-CT 40/6.25 Tablet can be taken with tizanidine if prescribed by your doctor. Consult the prescriber if you experience symptoms of low blood pressure, such as headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate. Be cautious when getting up from a sitting or lying position. Do not discontinue the medications without consulting a doctor.
Severe
How does the drug interact with Telfirst-CT 40/6.25 Tablet:
Taking quinapril with Telfirst-CT 40/6.25 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Telfirst-CT 40/6.25 Tablet can be taken with quinapril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium, such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking quinapril with Telfirst-CT 40/6.25 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Telfirst-CT 40/6.25 Tablet can be taken with quinapril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium, such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Severe
How does the drug interact with Telfirst-CT 40/6.25 Tablet:
Co-administration of Telfirst-CT 40/6.25 Tablet may significantly increase the blood levels of lithium.
How to manage the interaction:
Although there is a possible interaction, Telfirst-CT 40/6.25 Tablet can be taken with lithium if prescribed by the doctor. Consult the prescriber if you experience symptoms of lithium intoxication such as drowsiness, dizziness, confusion, loose stools, vomiting, muscle weakness, muscle incoordination, shaking of hands and legs, blurred vision, ringing in the ear, excessive thirst, or increased urination. Do not discontinue the medication without consulting a doctor.
Co-administration of Telfirst-CT 40/6.25 Tablet may significantly increase the blood levels of lithium.
How to manage the interaction:
Although there is a possible interaction, Telfirst-CT 40/6.25 Tablet can be taken with lithium if prescribed by the doctor. Consult the prescriber if you experience symptoms of lithium intoxication such as drowsiness, dizziness, confusion, loose stools, vomiting, muscle weakness, muscle incoordination, shaking of hands and legs, blurred vision, ringing in the ear, excessive thirst, or increased urination. Do not discontinue the medication without consulting a doctor.
Severe
How does the drug interact with Telfirst-CT 40/6.25 Tablet:
Coadministration of enalapril with Telfirst-CT 40/6.25 Tablet may increase the risk of hyperkalemia (high potassium levels in the blood), hypotension, syncope (fainting), and renal failure due to additive or synergistic effects. If you are elderly, dehydrated, or have a history of renal or heart illness, your risk is enhanced.
How to manage the interaction:
Although taking Enalapril together with Telfirst-CT 40/6.25 Tablet may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, papayas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Coadministration of enalapril with Telfirst-CT 40/6.25 Tablet may increase the risk of hyperkalemia (high potassium levels in the blood), hypotension, syncope (fainting), and renal failure due to additive or synergistic effects. If you are elderly, dehydrated, or have a history of renal or heart illness, your risk is enhanced.
How to manage the interaction:
Although taking Enalapril together with Telfirst-CT 40/6.25 Tablet may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, papayas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Severe
How does the drug interact with Telfirst-CT 40/6.25 Tablet:
Taking lisinopril with Telfirst-CT 40/6.25 Tablet may increase the levels of potassium in blood.
How to manage the interaction:
Although there is a possible interaction, Telfirst-CT 40/6.25 Tablet can be taken with lisinopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications.
Taking lisinopril with Telfirst-CT 40/6.25 Tablet may increase the levels of potassium in blood.
How to manage the interaction:
Although there is a possible interaction, Telfirst-CT 40/6.25 Tablet can be taken with lisinopril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications.
Drug-Food Interactions
CHLORTHALIDONE-6.25MG+TELMISARTAN-40MGPotassium rich foods
Moderate
Drug-Food Interactions
Login/Sign Up
CHLORTHALIDONE-6.25MG+TELMISARTAN-40MGPotassium rich foods
Moderate
Common Foods to Avoid:
Lentils, Orange Juice, Oranges, Raisins, Potatoes, Salmon Dried, Spinach, Sweet Potatoes, Tomatoes, Coconut Water, Beans, Beetroot, Broccoli, Bananas, Apricots, Avocado, Yogurt
How to manage the interaction:
Taking Telfirst-CT 40/6.25 Tablet along with potassium-containing salt substitutes or over-the-counter potassium supplements it may lead to high potassium levels in blood. Avoid high potassium rich food while taking Telfirst-CT 40/6.25 Tablet as it can possibly result in an interaction. However, consult a doctor if you experience weakness, irregular heartbeat, confusion and feelings of heaviness in the legs.
Lentils, Orange Juice, Oranges, Raisins, Potatoes, Salmon Dried, Spinach, Sweet Potatoes, Tomatoes, Coconut Water, Beans, Beetroot, Broccoli, Bananas, Apricots, Avocado, Yogurt
How to manage the interaction:
Taking Telfirst-CT 40/6.25 Tablet along with potassium-containing salt substitutes or over-the-counter potassium supplements it may lead to high potassium levels in blood. Avoid high potassium rich food while taking Telfirst-CT 40/6.25 Tablet as it can possibly result in an interaction. However, consult a doctor if you experience weakness, irregular heartbeat, confusion and feelings of heaviness in the legs.
Product Substitutes
शराब
असुरक्षित
आपको शराब का सेवन न करने की सलाह दी जाती है और टेलफर्स्ट-सीटी 40/6.25 टैबलेट 15's उनींदापन, चक्कर आना और लीवर की क्षति जैसे अप्रिय दुष्प्रभावों से बचने के लिए।
गर्भावस्था
असुरक्षित
टेलफर्स्ट-सीटी 40/6.25 टैबलेट 15's गर्भावस्था के दौरान अनुशंसित नहीं है क्योंकि यह श्रेणी D गर्भावस्था की दवा है। यह दवा भ्रूण को नुकसान पहुंचा सकती है और अजन्मे बच्चे (भ्रूण) को प्रभावित कर सकती है।
स्तनपान
असुरक्षित
टेलफर्स्ट-सीटी 40/6.25 टैबलेट 15's स्तन के दूध से गुजरने के लिए जाना जाता है, लेकिन बच्चे पर इसका प्रभाव ज्ञात नहीं है। इसलिए, स्तनपान कराने से पहले, अपने डॉक्टर को इस बारे में बताएं। या तो आपको टेलफर्स्ट-सीटी 40/6.25 टैबलेट 15's का उपयोग करने के लिए स्तनपान बंद करने की आवश्यकता है, या आपको टेलफर्स्ट-सीटी 40/6.25 टैबलेट 15's लेना बंद करने की आवश्यकता है।
ड्राइविंग
असुरक्षित
सावधानी से गाड़ी चलाएँ, टेलफर्स्ट-सीटी 40/6.25 टैबलेट 15's आमतौर पर उनींदापन का कारण बनता है और ड्राइविंग क्षमता को प्रभावित करता है।
जिगर
सावधानी
टेलफर्स्ट-सीटी 40/6.25 टैबलेट 15's सावधानी के साथ लेना है, खासकर यदि आपको लीवर की बीमारी का इतिहास रहा है। आपका डॉक्टर आपकी चिकित्सा स्थिति और उपचार के प्रति आपकी प्रतिक्रिया के आधार पर खुराक को बदल देगा।
गुर्दा
असुरक्षित
पुरानी किडनी रोग (गंभीर गुर्दे की हानि) के रोगियों में अनुशंसित नहीं है। गंभीर गुर्दे की हानि वाले रोगियों में सुरक्षा और प्रभावशीलता स्थापित नहीं की गई है।
बच्चे
सावधानी
बच्चों में टेलफर्स्ट-सीटी 40/6.25 टैबलेट 15's की प्रभावकारिता और सुरक्षा स्थापित नहीं की गई है। यदि निर्धारित किया जाता है, तो यह कड़ाई से चिकित्सा पर्यवेक्षण के तहत होना चाहिए और केवल तभी जब लाभ नुकसान से अधिक हों।
Have a query?
Customers Also Bought
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
